Privia Health Group (NASDAQ:PRVA) Given New $32.00 Price Target at JPMorgan Chase & Co.
Privia Health Group (NASDAQ:PRVA – Get Free Report) had its price target raised by investment analysts at JPMorgan Chase & Co. from $29.00 to $32.00 in a note issued to investors on Wednesday,Benzinga reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective points to a potential upside […]
Privia Health Group (NASDAQ:PRVA – Get Free Report) had its price target raised by investment analysts at JPMorgan Chase & Co. from $29.00 to $32.00 in a note issued to investors on Wednesday,Benzinga reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective points to a potential upside […]
